Pharmaceuticals France

France Parenteral Nutrition Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

France Parenteral Nutrition Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $196.0 Mn Placeholder estimate
Estimate 2025 $206.0 Mn 2.6% of the global market
Projected 2034 $322.3 Mn 56.5% Adds $116.3 Mn over 9 forecast years
CAGR 2025–2034 5.1% Faster than 26% of 180 Pharmaceuticals markets here
Key players 5
  • France is 2.62% of the global market.
  • In Europe, the largest is Germany at $238.2 Mn.
  • Fastest growing: Russia at 5.8% a year.
  • France ranks 3rd of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$116.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Parenteral Nutrition Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $196.0 Mn — —
2025 (base) $206.0 Mn +$10.0 Mn —
2026 (forecast) $216.5 Mn +$10.5 Mn +5.1%
2027 (forecast) $227.6 Mn +$11.0 Mn +10.5%
2028 (forecast) $239.2 Mn +$11.6 Mn +16.1%
2029 (forecast) $251.4 Mn +$12.2 Mn +22%
2030 (forecast) $264.2 Mn +$12.8 Mn +28.2%
2031 (forecast) $277.7 Mn +$13.5 Mn +34.8%
2032 (forecast) $291.8 Mn +$14.2 Mn +41.7%
2033 (forecast) $306.7 Mn +$14.9 Mn +48.9%
2034 (forecast) $322.3 Mn +$15.6 Mn +56.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

France Parenteral Nutrition Market Analysis at a glance
Market size, 2025$206.0 Mn placeholder estimate
Forecast, 2034$322.3 Mn placeholder estimate
Growth (CAGR), 2025–20345.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersFresenius Kabi AG, Baxter International, B. Braun, ICU Medical, Otsuka Pharmaceutical Co., Ltd. (see all)
Regulator in FranceANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France Parenteral Nutrition Market Analysis Executive Summary

Parenteral nutrition feeds patients through a vein when they cannot eat or absorb food through the gut.

Key segments of the parenteral Nutrition market include product (Amino Acids, Lipid Emulsions and Carbohydrates) and setting (Hospitals and Home Care).

Bar chart: France Parenteral Nutrition market size, 2024–2034, placeholder estimates. $196.0 Mn in 2024, $206.0 Mn in 2025 and $322.3 Mn in 2034, 5.1% CAGR.
France Parenteral Nutrition market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France Parenteral Nutrition Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the parenteral Nutrition market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the parenteral Nutrition market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the parenteral Nutrition market.

Competitive Landscape for Parenteral Nutrition Market in France

The parenteral Nutrition market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Parenteral Nutrition Market in France

Parenteral Nutrition in France: rules and payment

Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by ANSM, the French medicines agency.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for parenteral Nutrition. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Parenteral Nutrition right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Parenteral Nutrition in context

France compared

  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 3rd highest of the 6 countries we cover in Europe.[1]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 6th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 22.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Parenteral Nutrition market in France?
Placeholder estimate: about $206.0 Mn in 2025, rising to about $322.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Parenteral Nutrition market in France growing?
Placeholder estimate: about 5.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Parenteral Nutrition market report cover?
The report splits the market by product (Amino Acids, Lipid Emulsions, Carbohydrates, Vitamins and Trace Elements), setting (Hospitals, Home Care) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Parenteral Nutrition market?
Key players include Fresenius Kabi AG, Baxter International, B. Braun, ICU Medical and Otsuka Pharmaceutical Co., Ltd..
What is driving the Parenteral Nutrition market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the parenteral Nutrition market.
Who regulates Parenteral Nutrition in France?
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by ANSM, the French medicines agency. Source: ANSM, French medicines agency. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
How much research is published on Parenteral Nutrition?
PubMed lists 4,884 papers on Parenteral Nutrition added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in France

See all

Related on nutrition and hospital

See the topic